10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
19.15
0.00 (0.00%)
At close: Feb 11, 2026, 4:00 PM EST
19.17
+0.02 (0.10%)
After-hours: Feb 11, 2026, 7:30 PM EST
10x Genomics Stock Forecast
Stock Price Forecast
The 14 analysts that cover 10x Genomics stock have a consensus rating of "Hold" and an average price target of $16.18, which forecasts a -15.51% decrease in the stock price over the next year. The lowest target is $6.50 and the highest is $22.
Price Target: $16.18 (-15.51%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for 10x Genomics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 5 | 5 | 6 | 8 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | +4.44% | Jan 27, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $20 → $22 | Hold | Maintains | $20 → $22 | +14.88% | Jan 16, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $15 → $20 | Hold | Maintains | $15 → $20 | +4.44% | Jan 7, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $15 → $18 | Hold | Maintains | $15 → $18 | -6.01% | Jan 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $19 → $20 | Strong Buy | Maintains | $19 → $20 | +4.44% | Dec 22, 2025 |
Financial Forecast
Revenue This Year
642.24M
from 610.79M
Increased by 5.15%
Revenue Next Year
617.38M
from 642.24M
Decreased by -3.87%
EPS This Year
-0.43
from -1.52
EPS Next Year
-0.96
from -0.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 675.2M | 660.0M | ||||
| Avg | 642.2M | 617.4M | ||||
| Low | 618.3M | 584.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.5% | 2.8% | ||||
| Avg | 5.1% | -3.9% | ||||
| Low | 1.2% | -9.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.29 | -0.56 | ||||
| Avg | -0.43 | -0.96 | ||||
| Low | -0.49 | -1.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.